Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Depletion of astrocytic transglutaminase 2 improves injury outcomes.

Monteagudo A, Feola J, Natola H, Ji C, Pröschel C, Johnson GVW.

Mol Cell Neurosci. 2018 Oct;92:128-136. doi: 10.1016/j.mcn.2018.06.007. Epub 2018 Jun 30.

PMID:
29969654
2.

Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.

Monteagudo A, Ji C, Akbar A, Keillor JW, Johnson GVW.

Biochem Biophys Res Commun. 2017 Jan 22;482(4):942-947. doi: 10.1016/j.bbrc.2016.11.137. Epub 2016 Nov 27.

3.

The complex role of transglutaminase 2 in glioblastoma proliferation.

Gundemir S, Monteagudo A, Akbar A, Keillor JW, Johnson GVW.

Neuro Oncol. 2017 Feb 1;19(2):208-218. doi: 10.1093/neuonc/now157.

4.

Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells.

Méndez J, Morales Cruz M, Delgado Y, Figueroa CM, Orellano EA, Morales M, Monteagudo A, Griebenow K.

Mol Pharm. 2014 Jan 6;11(1):102-11. doi: 10.1021/mp400400j. Epub 2013 Dec 10.

5.

Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.

Alzayady KJ, Wagner LE 2nd, Chandrasekhar R, Monteagudo A, Godiska R, Tall GG, Joseph SK, Yule DI.

J Biol Chem. 2013 Oct 11;288(41):29772-84. doi: 10.1074/jbc.M113.502203. Epub 2013 Aug 16.

6.

Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.

Méndez J, Monteagudo A, Griebenow K.

Bioconjug Chem. 2012 Apr 18;23(4):698-704. doi: 10.1021/bc200301a. Epub 2012 Mar 13.

Supplemental Content

Loading ...
Support Center